secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOGEN INC. (BIIB)
CIK:        0000875045
Form:       8-K
Filed at:   2024-06-25T23:59:59+00:00
Accession:  0001193125-24-167938
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biogen shareholders approve officer exculpation amendment and elect nine directors at annual meeting
--------------------------------------------------------------------------------

- Certificate of Amendment filed to allow officer exculpation to extent permitted by Delaware law; approved with 103.1M votes for, 16.3M against.
- All nine director nominees elected with wide margins; Monish Patolawala received 119.1M votes for, highest count.
- Ratification of PwC as independent auditor for FY2024: 123.7M for, 5.3M against.
- Advisory vote on executive compensation passed with 114.4M for, 5.1M against.
- Adoption of 2024 Omnibus Equity Plan and 2024 Employee Stock Purchase Plan both approved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875045/000119312524167938/0001193125-24-167938-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875045/000119312524167938/d840763d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-167938

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer